Medtronic plc - Common Stock (MDT) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
MDT on NYSE
Shares outstanding
1,282,559,305
Price per share
$96.06
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,073,648,907
Total reported value
$102,259,293,981
% of total 13F portfolios
0.09%
Share change
-8,628,849
Value change
-$655,172,264
Number of holders
2,139
Price from insider filings
$96.06
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Medtronic plc - Common Stock (MDT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10% $11,837,817,172 130,949,305 The Vanguard Group 28 Nov 2025
BlackRock, Inc. 6.9% $7,560,548,289 88,655,585 BlackRock, Inc. 31 Mar 2025

As of 30 Sep 2025, 2,139 institutional investors reported holding 1,073,648,907 shares of Medtronic plc - Common Stock (MDT). This represents 84% of the company’s total 1,282,559,305 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Medtronic plc - Common Stock (MDT) together control 53% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.9% 127,072,962 +0.13% 0.18% $12,102,428,902
BlackRock, Inc. 9.3% 119,568,806 -2.4% 0.2% $11,387,733,085
STATE STREET CORP 4.7% 60,460,537 +1% 0.2% $5,800,549,521
JPMORGAN CHASE & CO 4.1% 52,195,764 +49% 0.32% $4,971,126,646
Capital Research Global Investors 2.4% 30,692,989 -16% 0.55% $2,923,194,833
GEODE CAPITAL MANAGEMENT, LLC 2.2% 27,647,562 -2.1% 0.17% $2,620,412,217
BANK OF AMERICA CORP /DE/ 1.9% 24,247,143 +9.4% 0.17% $2,309,297,815
Bank of New York Mellon Corp 1.7% 21,468,260 +0.9% 0.37% $2,044,637,177
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.6% 21,086,499 +0.47% 0.62% $2,008,278,165
MORGAN STANLEY 1.6% 20,232,249 +6.3% 0.12% $1,926,919,715
DEUTSCHE BANK AG\ 1.4% 17,736,697 -6.6% 0.57% $1,689,243,022
Invesco Ltd. 1.3% 16,204,661 -8.2% 0.24% $1,543,331,936
ROYAL BANK OF CANADA 1.1% 14,237,196 +28% 0.24% $1,355,952,000
AMERIPRISE FINANCIAL INC 0.98% 12,534,866 -14% 0.27% $1,193,934,134
NORTHERN TRUST CORP 0.95% 12,129,386 -0.79% 0.15% $1,155,202,724
FRANKLIN RESOURCES INC 0.9% 11,492,577 -2.4% 0.27% $1,094,553,025
RAYMOND JAMES FINANCIAL INC 0.87% 11,203,865 +3% 0.34% $1,067,054,924
UBS Group AG 0.87% 11,202,878 +96% 0.21% $1,066,962,101
WELLINGTON MANAGEMENT GROUP LLP 0.79% 10,189,586 +35% 0.17% $970,456,172
First Eagle Investment Management, LLC 0.76% 9,735,038 +0.03% 1.7% $927,165,031
Legal & General Group Plc 0.74% 9,483,711 +9.6% 0.2% $903,228,631
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.67% 8,634,182 -16% 0.18% $822,319,495
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.64% 8,175,791 +0.19% 0.12% $778,662,335
GOLDMAN SACHS GROUP INC 0.64% 8,164,720 -54% 0.11% $777,607,982
ALLIANCEBERNSTEIN L.P. 0.62% 7,921,480 +42% 0.24% $754,441,755

Institutional Holders of Medtronic plc - Common Stock (MDT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 8,838,703 $853,597,623 +$219,534,473 $96.06 156
2025 Q3 1,073,648,907 $102,259,293,981 -$655,172,264 $95.24 2,139
2025 Q2 1,082,710,412 $94,412,733,436 +$1,865,139,398 $87.17 2,115
2025 Q1 1,059,290,401 $95,156,907,148 +$166,941,987 $89.86 2,131
2024 Q4 1,062,854,878 $84,977,260,840 +$1,807,847,541 $79.88 2,074
2024 Q3 1,033,136,252 $93,014,958,025 -$2,043,869,469 $90.03 2,029
2024 Q2 1,059,876,909 $83,464,308,696 -$1,481,559,430 $78.71 1,989
2024 Q1 1,079,210,661 $94,002,579,037 -$1,214,193,177 $87.15 2,045
2023 Q4 4,165,213 $343,139,637 -$277,045,906 $82.38 26
2023 Q3 1,071,546,114 $83,964,448,139 +$217,289,550 $78.36 1,916
2023 Q2 1,069,149,070 $94,145,347,612 -$1,524,797,536 $88.10 2,001
2023 Q1 1,066,830,210 $86,002,481,430 +$652,736,874 $80.62 1,933
2022 Q4 1,077,623,680 $83,805,778,628 -$261,235,794 $77.72 1,895
2022 Q3 1,081,854,697 $87,490,930,923 +$1,282,677,229 $80.75 1,865
2022 Q2 1,035,846,747 $92,961,775,558 +$391,974,366 $89.75 1,946
2022 Q1 1,056,291,134 $117,213,235,844 -$163,554,184 $110.95 2,034
2021 Q4 1,056,743,214 $109,393,075,959 -$148,107,145 $103.45 1,997
2021 Q3 1,053,067,685 $132,028,668,186 -$562,393,990 $125.35 1,965
2021 Q2 1,062,502,790 $131,905,034,827 -$636,042,247 $124.13 1,939
2021 Q1 1,065,519,637 $125,883,117,632 +$687,547,372 $118.13 1,915
2020 Q4 1,057,175,694 $123,818,409,448 -$91,110,103 $117.14 1,888
2020 Q3 1,064,274,388 $110,575,068,627 -$1,074,645,362 $103.92 1,756
2020 Q2 1,050,869,314 $96,430,609,217 +$62,178,014 $91.70 1,702
2020 Q1 1,053,140,786 $95,025,260,619 -$575,809,923 $90.18 1,689
2019 Q4 1,067,466,241 $121,148,596,923 +$952,564,032 $113.45 1,752
2019 Q3 1,063,795,403 $115,563,164,777 -$598,732,300 $108.62 1,591
2019 Q2 1,079,371,853 $105,109,832,217 +$3,465,928,381 $97.39 1,558
2019 Q1 1,065,876,805 $97,096,499,392 -$706,358,651 $91.08 1,537
2018 Q4 1,073,903,384 $97,717,413,262 -$744,510,997 $90.96 1,501
2018 Q3 1,075,193,915 $105,756,744,902 +$2,078,547,504 $98.37 1,430
2018 Q2 1,059,800,131 $90,723,224,931 -$992,007,292 $85.61 1,352
2018 Q1 1,094,578,973 $87,793,506,470 -$252,809,030 $80.22 1,321
2017 Q4 1,100,243,028 $88,850,178,764 -$1,101,102,238 $80.75 1,339
2017 Q3 1,115,730,346 $86,777,562,441 +$1,184,456,939 $77.77 1,228
2017 Q2 1,097,581,153 $97,466,588,137 -$1,442,555,281 $88.75 1,217
2017 Q1 1,127,723,802 $90,871,241,557 +$6,125,687,170 $80.56 1,217
2016 Q4 1,135,865,039 $80,922,705,703 +$5,525,503,853 $71.23 1,202
2016 Q3 1,037,528,403 $89,602,509,947 -$1,755,521,026 $86.40 1,190
2016 Q2 1,050,610,561 $91,156,042,130 -$139,395 $86.77 1,175
2016 Q1 1,064,854,140 $79,859,697,698 -$199,045,653 $75.00 1,151
2015 Q4 1,077,810,000 $82,912,987,448 -$981,956,518 $76.92 1,157
2015 Q3 1,092,888,659 $73,168,707,001 +$862,033,675 $66.94 1,104
2015 Q2 1,067,241,514 $79,082,793,165 -$929,220,683 $74.10 1,138
2015 Q1 1,096,063,293 $85,480,266,930 +$83,526,449,925 $77.99 1,078
2014 Q4 24,671,788 $1,781,443,607 +$1,423,792,014 $72.20 97
2014 Q3 4,575,414 $283,446,000 -$9,430,398 $61.95 8
2014 Q2 4,727,254 $301,410,000 +$290,193,769 $63.76 7
2014 Q1 191,962 $12,028,598 +$824,650 $61.54 8